Cocktail of vaccines for children in China

China Perspective

CHINA has incorporated BCG vaccine, poliomyelitis vaccine, chin cough vaccine, diphtheria vaccine and tetanus vaccine into its planned immunity programme for children, according to Health Ministry officials. Governments of all levels will pay for these vaccines.  

Improving humans' immunity level by vaccination is the most effective method to control and get rid of infectious disease. It is also a low-cost method.  

Since China's adoption of planned immunity for children in 1970s, the vaccination rate among children in all provinces, counties and townships in China has reached 85%. 

The occurrence rate of infectious diseases has dropped notably. In 2002, the World Health Organisation confirmed China's status as country free from poliomyelitis. Despite the achievements accomplished, some problems and difficulties still exist in planned immunity. 

The rate of vaccination for children in some regions has decreased. The occurrence rate of some controllable diseases bounces back in some regions.  

The ministry has urged all localities to further strengthen guidance for the planned immunity and clarify the government's responsibility in public health. 

More funds are required for the planned immunity. – People's Daily  

Asia News Network

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3

Next In Regional

Ismail Sabri: 106 factories ordered to close for not complying with SOP
Subaru to temporarily shut its plants in July due to chip shortage
Lawmaker: North Korea hackers target South Korea nuclear think tank
Tenaga, plantations power KLCI sharply higher
Drink up, drink fast, drink alone? Tokyo to ease alcohol curbs
Malaysia maintains CPO export tax at 8% for July
India should brace for third COVID-19 wave by Oct, say health experts
HSBC: Malaysia, Singapore regional hubs for green financing
FDI slips to lowest since 2009 due to pandemic
Crude oil extends slump as traders weigh dollar against demand

Stories You'll Enjoy